Benzothiazole-6-carboxylic acid
CAS: 3622-35-3
Ref. 3D-FB12574
| 1g | Discontinued | ||
| 2g | Discontinued | ||
| 5g | Discontinued | ||
| 250mg | Discontinued | ||
| 500mg | Discontinued |
Product Information
Name:
Benzothiazole-6-carboxylic acid
Synonyms:
- 1,3-Benzothiazole-6-Carboxylic Acid
- 6-Benzothiazolecarboxylic acid
- Benzo[D]Thiazole-6-Carboxylic Acid
- 1: PN: WO2008156676 SEQID: 1 claimed sequence
Description:
Benzothiazole-6-carboxylic acid (BZCA) is a benzothiazole compound that is resistant to protein degradation, and is therefore stable in wastewater treatment. It has been shown to be effective against infectious diseases such as viral infections and bowel disease. BZCA has also been shown to inhibit the growth of lymphoproliferative cells, which are involved in the progression of cancer. BZCA has also been shown to inhibit the transcription process by binding to the DNA polymerase enzyme, preventing it from transcribing DNA and halting RNA synthesis. This drug can be used as a molecular probe for studying the molecular pathogenesis of erythropoietic protoporphyria in humans and other animals.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
179.2 g/mol
Formula:
C8H5NO2S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
